English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Zydus Lifesciences Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

76/100
1,009.00
9.50 (0.95%)

As on 23 Oct, 2025 | 03:58

Open Trading A/c
Day Range
1003.05
1013.95
L H
52 Week Range
795.00
1059.05
L H
Volume
693,670
*
i

* BSE Market Depth (23 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
100 1007.00 1007.25 1
1 1006.00 1008.50 4
57 1005.50 1008.60 122
122 1005.45 1008.65 122
212 1005.40 1009.25 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
76/100
1,006.60
6.70 (0.67%)

As on 23 Oct, 2025 | 04:01

Open Trading A/c
Day Range
1002.70
1012.50
L H
52 Week Range
797.05
1059.00
L H
Volume
58,469
*
i

* BSE Market Depth (23 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
100 1007.00 1007.25 1
1 1006.00 1008.50 4
57 1005.50 1008.60 122
122 1005.45 1008.65 122
212 1005.40 1009.25 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
76/100
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Bid / Ask
/
Advance Chart
76/100
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Bid / Ask
/
Advance Chart
NSE
MC Essentials
76% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 1,013.95
          Previous Close 999.50
          Volume 693,670.00
          Value (Lacs) 6,999.13
            VWAP 1,009.13
          Beta
          Mkt Cap (Rs. Cr.) 101,529
          High 1,013.95
          Low 1,003.05
          UC Limit 1,099.45
          LC Limit 899.55
          52 Week High 1,059.05
          52 Week Low 795.00
          Face Value 1.00
          All Time High 1,324.30
          All Time Low 5.53
          20D Avg Volume 939,700
          20D Avg Delivery(%) 55.28
          Book Value Per Share 216.89
          Dividend Yield 1.09
          TTM EPS See historical trend 45.56 (+6.12% YoY)
          TTM PE See historical trend 22.15 (Average PE)
          P/B See historical trend 4.66 (Average P/B)
          Sector PE 40.05

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          76/100
          Superior Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 4.73% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 74.99% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 17 years Zydus Lifesciences has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 12.01% (2022) 6.58% -8.89% (2021) -4.57% 1.99%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Cadila Health

          What's your call on Cadila Health today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          13 Aug, 2025

          ICICI Securities

          Reco Price 989.05 Target Price 910
          13 Aug, 2025

          Prabhudas Lilladher

          Reco Price 989.05 Target Price 970
          26 May, 2025

          Deven Choksey

          Reco Price 912.55 Target Price 1069
          21 May, 2025

          ICICI Securities

          Reco Price 889.75 Target Price 910
          21 May, 2025

          Prabhudas Lilladher

          Reco Price 889.75 Target Price 970
          07 Feb, 2025

          KRChoksey

          Reco Price 993.95 Target Price 1201
          Show More
          REFINITIV Report

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          30 Aug, 2024

          Ubs Principal Capital Asia Limited

          Qty 6701664 Price 1128.11 % Traded 0.67

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Zydus Life 1,009.00 0.95 101,529.01 22.15 4.65 18.89 0.33 4,614 23,241 0.13
          Sun Pharma 1,689.90 -0.04 405,463.62 39.09 5.87 15.13 -8.13 10,980 52,578 0.03
          Divis Labs 6,565.50 -0.33 174,293.40 75.58 12.71 14.63 14.63 2,191 9,360 0.00
          Cipla 1,645.10 -1.11 132,885.53 24.64 4.69 16.90 7.96 5,291 27,547 0.00
          Torrent Pharma 3,614.10 0.65 122,317.57 61.10 16.30 25.17 6.53 1,911 11,516 0.40
          + See More

          About the Company

          Cadila Healthcare Ltd operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.The company has in-licensing alliances with global multinationals such as Schering AG, Boehringer Ingelheim, Viatris, etc.Their product range includes Formulations that cater to various therapeutic areas such as cardiovascular, gastrointestinal, respiratory, pain management, CNS, anti-infectives, oncology, neurosciences, dermatology and nephrology segments and Consumer product division-brands like Sugar Free, Nutralite and Everyuth.
          {"success":1,"data":[]}

          • Registered Office

            No Data For Registered Office.

          • Registrars

            No Data For Registrars.

          • Management

            No Data For Management.

          • Included In

            No Data For Included In.

          • Details

            No Data For Details.
          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347